Literature DB >> 1500237

Porphyria cutanea tarda and human immunodeficiency virus infection.

A Blauvelt1, H R Harris, D J Hogan, F Jimenez-Acosta, I Ponce, R J Pardo.   

Abstract

Porphyria cutanea tarda (PCT), a relatively uncommon disease, has recently been reported in patients infected with the human immunodeficiency virus (HIV). Although PCT and HIV infection may co-exist by chance, the increasing number of reported cases suggest that HIV or an associated factor triggers the development of PCT in predisposed individuals. We report four additional cases of PCT in HIV seropositive patients and review the previously reported cases. The possible links between PCT and HIV are discussed. We believe the diagnosis of PCT should prompt investigation for HIV infection in all patients.

Entities:  

Mesh:

Year:  1992        PMID: 1500237     DOI: 10.1111/j.1365-4362.1992.tb02693.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  3 in total

1.  Highly active antiretroviral therapy leading to resolution of porphyria cutanea tarda in a patient with AIDS and hepatitis C.

Authors:  J D Rich; E Mylonakis; R Nossa; R M Chapnick
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

2.  Hepatoerythropoietic porphyria precipitated by viral hepatitis.

Authors:  R J Hift; P N Meissner; G Todd
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

3.  Porphyria cutanea tarda in a human immunodeficiency virus-infected patient: A rare scenario in India.

Authors:  Ramesh M Bhat; Malcolm Pinto; S Dandakeri; Srinath M Kambil
Journal:  Indian J Sex Transm Dis AIDS       Date:  2014-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.